Business Description
Kangstem Biotech Co Ltd
ISIN : KR7217730001
Compare
Compare
Traded in other countries / regions
217730.Korea IPO Date
2015-12-21Description
Kangstem Biotech Co Ltd develops technology to isolate the non-hematological system stem cell with conversion and purity from the cord blood and to culture large quantity. Its Furestem therapies include Furestem-AD, Furestem-RA and Furestem-CD. Its businesses include cord blood-derived stem cell therapy business; cord blood-derived stem cell conditioned media business; and stem cell culture media business.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.95 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | -1.28 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.02 | |||||
Beneish M-Score | -1.51 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.2 | |||||
3-Year EBITDA Growth Rate | 6.5 | |||||
3-Year EPS without NRI Growth Rate | 2.6 | |||||
3-Year FCF Growth Rate | 8.8 | |||||
3-Year Book Growth Rate | -18.3 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 27.63 | |||||
9-Day RSI | 34.91 | |||||
14-Day RSI | 36.03 | |||||
6-1 Month Momentum % | -11.2 | |||||
12-1 Month Momentum % | 6.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.09 | |||||
Quick Ratio | 3.03 | |||||
Cash Ratio | 2.35 | |||||
Days Inventory | 29.11 | |||||
Days Sales Outstanding | 26.7 | |||||
Days Payable | 15.32 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19.7 | |||||
Shareholder Yield % | 1.42 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 21.69 | |||||
Operating Margin % | -167.94 | |||||
Net Margin % | -83.86 | |||||
FCF Margin % | -147.97 | |||||
ROE % | -22.77 | |||||
ROA % | -13.53 | |||||
ROIC % | -37.59 | |||||
ROC (Joel Greenblatt) % | -35.58 | |||||
ROCE % | -19.14 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.58 | |||||
PB Ratio | 1.74 | |||||
Price-to-Tangible-Book | 1.75 | |||||
EV-to-EBIT | -6.89 | |||||
EV-to-EBITDA | -11.2 | |||||
EV-to-Revenue | 5.75 | |||||
EV-to-FCF | -3.88 | |||||
Price-to-Net-Current-Asset-Value | 4.02 | |||||
Price-to-Net-Cash | 7.02 | |||||
Earnings Yield (Greenblatt) % | -14.51 | |||||
FCF Yield % | -19.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kangstem Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 11,643.721 | ||
EPS (TTM) (â‚©) | -226 | ||
Beta | 1.48 | ||
Volatility % | 87.68 | ||
14-Day RSI | 36.03 | ||
14-Day ATR (â‚©) | 105.842448 | ||
20-Day SMA (â‚©) | 1683.3 | ||
12-1 Month Momentum % | 6.89 | ||
52-Week Range (â‚©) | 1166 - 3920 | ||
Shares Outstanding (Mil) | 55.94 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kangstem Biotech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kangstem Biotech Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Kangstem Biotech Co Ltd Frequently Asked Questions
What is Kangstem Biotech Co Ltd(XKRX:217730)'s stock price today?
The current price of XKRX:217730 is â‚©1600.00. The 52 week high of XKRX:217730 is â‚©3920.00 and 52 week low is â‚©1166.00.
When is next earnings date of Kangstem Biotech Co Ltd(XKRX:217730)?
The next earnings date of Kangstem Biotech Co Ltd(XKRX:217730) is .
Does Kangstem Biotech Co Ltd(XKRX:217730) pay dividends? If so, how much?
Kangstem Biotech Co Ltd(XKRX:217730) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |